美国Supernus Pharma
专注于癫痫等中枢神经系统治疗的制药公司Supernus Pharmaceuticals Inc。尽管Supernus研发的药物迄今没有一种获得监管部门批准，而且也没有从中赚得一分钱，但该公司拥有比传统医药创业公司更丰富的经验：它是于2005年在Shire Laboratories基础上创建的，同时使用以前用过的相同专有技术系统开发已获得批准并上市的治疗手段。

With more than 20 years of experience, we are a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) disorders.
We are developing several product candidates in neurology and psychiatry to address unmet medical needs and opportunities in epilepsy, attention-deficit hyperactivity disorder (ADHD) and its coexisting disorders, and depression.
We are developing differentiated products by leveraging our proprietary and in-licensed technologies. We use such technologies to discover and develop novel uses for known drug compounds and to enhance their therapeutic benefits. Our focus on known drug compounds with established mechanisms of action reduces the risks, costs, and time typically associated with pharmaceutical product development.